Cargando…
A High Throughput Assay for Screening Host Restriction Factors and Antivirals Targeting Influenza A Virus
Influenza A virus (IAV) is a human respiratory pathogen that causes seasonal epidemics and occasional global pandemics with devastating levels of morbidity and mortality. Currently approved treatments against influenza are losing effectiveness, as new viral strains are often refractory to convention...
Autores principales: | Wang, Lingyan, Li, Wenjun, Li, Shitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891343/ https://www.ncbi.nlm.nih.gov/pubmed/27375580 http://dx.doi.org/10.3389/fmicb.2016.00858 |
Ejemplares similares
-
Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction
por: Wang, Lingyan, et al.
Publicado: (2017) -
Influenza A Virus–Host Protein Interactions Control Viral Pathogenesis
por: Zhao, Mengmeng, et al.
Publicado: (2017) -
Assay development and high-throughput antiviral drug screening against Bluetongue virus
por: Li, Qianjun, et al.
Publicado: (2009) -
TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase
por: Fu, Bishi, et al.
Publicado: (2015) -
Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
por: Eichelberger, Maryna C, et al.
Publicado: (2008)